PSPDFKit Extends Document Technology Platform With Strategic Acquisitions of ORPALIS and Aquaforest May 16, 2022 6:00 am|Combination advances PSPDFKit’s leadership in the digital document enablement space; Brings together complementary PDF SDKs and solutions to…
UpKeep Writes the Book on Asset Operations Management May 16, 2022 6:00 am|New Paradigm Defines the Future of Maintenance, Reliability, and Operations
Highlander Partners Announces the Formation of High Point Aerotechnologies LLC, Appoints Jim Gavrilis as President and CEO May 16, 2022 6:00 am|Mr. Gavrilis Will Lead High Point’s Efforts in Establishing a Platform in the Counter Unmanned Aircraft Systems (“C-UAS”)…
RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools May 16, 2022 6:00 am|CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and LOS ANGELES, May 16, 2022 /PRNewswire/ — RadNet, Inc., (NASDAQ: RDNT) today announced…
i-80 Gold Announces Approval for Listing on the NYSE American May 16, 2022 6:00 am|RENO, Nev., May 16, 2022 /PRNewswire/ – i-80 GOLD CORP. (TSX: IAU) (OTCQX: IAUCF) (“i-80”, or the “Company”) is pleased…
New Report Estimates the Metaverse Could Contribute 2.8% to Global GDP in Its First Decade May 16, 2022 6:00 am|The contribution to GDP in 2031 from the metaverse could be $3 trillion if adoption begins in 2022,…
Prota Therapeutics Achieves 51 Percent Peanut Allergy Remission Rate, First Company to Validate Significant Quality of Life Improvements Compared with Standard Care May 16, 2022 6:00 am|Children’s ability to eat peanut freely and safely delivers meaningful improvement in quality of life for families and…
Tenneco Supplying Intelligent Suspensions for New Mercedes-AMG SL-Class Roadsters May 16, 2022 6:00 am|SKOKIE, Ill., May 16, 2022 /PRNewswire/ — The much-anticipated 2022 Mercedes-AMG SL-Class of luxury roadsters will feature two…
McDonald's To Exit from Russia May 16, 2022 6:00 am|Company initiates process to sell its Russian business, seeks to include future employment for Russian employees as part…
Orna Therapeutics Announces First-in-Class, Breakthrough Data Demonstrating Potential of Circular RNA Platform at ASGCT 2022 May 16, 2022 6:00 am|Advances in oRNA expression and delivery enable pipeline of therapeutics across a diverse range of disease areas